Denali Therapeutics Inc. DNLI Milestone Triggered — Total collaboration revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
Under the Sanofi Collaboration Agreement, the Company is eligible to receive milestone payments totaling up to approximately $495.0 million upon achievement of certain clinical, regulatory and sales milestone events for Peripheral Products, and variable royalties on worldwide net sales. As of June 30, 2026, the Company had earned milestone payments of $100.0 million and had not recorded any product sales under the Sanofi Collaboration Agreement.
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue?
- Denali Therapeutics Inc. (DNLI) reported milestone triggered — total collaboration revenue of $25M in Q4 2026.
- How has Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue changed year-over-year?
- Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue decreased by 0.0% year-over-year, from $25M to $25M.
- What is the long-term trend for Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue?
- Over 3 years (2022 to 2026), Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue has grown at a 15.4% compound annual growth rate (CAGR), from $65M to $100M.
- What does milestone triggered — total collaboration revenue mean?
- Represents the aggregate revenue recognized from collaborative research and development agreements within a specific business segment. This metric captures the financial value derived from achieving contractually defined milestones or performance obligations in partnership with other entities. It serves as a key indicator of the commercial success and progress of the company's joint development programs.
Ask your AI about Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue.
Connect your AI assistant and compare segments, right in your chat.
